Key Product Details
Description: | KCC2 inhibitor |
Chemical Name: | N-(4-Methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide |
Purity: | ≥99% (HPLC) |
Molecular Weight: | 342.43 |
Customers also Viewed
Customers also Purchased
Citations for VU 0240551 (8)
Citations are publications that use Bio-Techne products. Selected citations for VU 0240551 include:
-
Marie-Pascale et al.
(2021)
Enhancing KCC2 activity decreases hyperreflexia and spasticity after chronic spinal cord injury.
Exp Neurol.
338:113605
PMID: 33453210 -
Alfredo et al.
(2020)
Enhancing neuronal chloride extrusion rescues α2/α3 GABAA-mediated analgesia in neuropathic pain.
Nat Commun.
11:869
PMID: 32054836 -
Ferando et al.
(2016)
Diminished KCC2 confounds synapse specificity of LTP during senescence.
Nat Neurosci.
19:1197
PMID: 27500406 -
Yi et al.
(2016)
Potentiation of Synaptic GluN2B NMDAR Currents by Fyn Kinase Is Gated through BDNF-Mediated Disinhibition in Spinal Pain Processing.
Cell Rep.
17:2753-2765
PMID: 27926876 -
Lavertu et al.
(2014)
Enhancing K-Cl co-transport restores normal spinothalamic sensory coding in a neuropathic pain model.
Brain.
137:724
PMID: 24369380 -
Gagnon et al.
(2013)
Chloride extrusion enhancers as novel therapeutics for neurological diseases.
Nat Med.
19:1524
PMID: 24097188 -
Haam et al.
(2012)
GABA is excitatory in adult vasopressinergic neuroendocrine cells.
J Neurosci.
32:572
PMID: 22238092 -
Doyon et al.
(2011)
Efficacy of synaptic inhibition depends on multiple, dynamically interacting mechanisms implicated in chloride homeostasis.
Purinergic Signal.
7:e1002149
PMID: 21931544
There are no citations that match your criteria.